A phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancer

ABSTRACT: Interventions: combination immunotherapy Primary outcome(s): safety Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2637344 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR